SkinHealth Systems Inc. Pre-Tax Income
SkinHealth Systems Inc. (SKIN) reported Pre-Tax Income of -$1.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-06
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$1.46M, a 107.80% decline year-over-year.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$6.81M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$4.81M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$10.64M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$5.94M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$29.55M.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$101.89M, a 324.73% decline from fiscal 2022.
- SkinHealth Systems Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was $45.34M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.46M 10-Q · filed 2026-08-06 | -$8.28M 10-Q · filed 2026-08-06 | -$13.08M derived: sum of 3 quarters · filed 2026-08-06 | -$23.73M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$6.81M 10-Q · filed 2026-05-07 | -$11.62M derived: sum of 2 quarters · filed 2026-05-07 | -$22.27M derived: sum of 3 quarters · filed 2026-05-07 | -$3.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$15.45M derived: sum of 2 quarters · filed 2026-03-12 | $3.27M derived: sum of 3 quarters · filed 2026-08-06 | -$5.94M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$10.64M 10-Q · filed 2025-11-06 | $8.07M derived: sum of 2 quarters · filed 2026-08-06 | -$1.13M 10-Q · filed 2025-11-06 | -$12.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $18.72M 10-Q · filed 2026-08-06 | $9.52M 10-Q · filed 2026-08-06 | -$2.20M derived: sum of 3 quarters · filed 2026-08-06 | -$18.55M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$9.20M 10-Q · filed 2026-05-07 | -$20.92M derived: sum of 2 quarters · filed 2026-05-07 | -$37.27M derived: sum of 3 quarters · filed 2026-05-07 | -$37.42M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$11.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$28.06M derived: sum of 2 quarters · filed 2026-03-12 | -$28.21M derived: sum of 3 quarters · filed 2026-03-12 | -$29.55M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$16.34M 10-Q · filed 2025-11-06 | -$16.49M derived: sum of 2 quarters · filed 2025-11-06 | -$17.83M 10-Q · filed 2025-11-06 | -$26.63M derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2024-06-30 | -$151.00K 10-Q · filed 2025-08-07 | -$1.49M 10-Q · filed 2025-08-07 | -$10.29M derived: sum of 3 quarters · filed 2026-03-12 | -$80.63M derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2024-03-31 | -$1.34M 10-Q · filed 2025-05-08 | -$10.14M derived: sum of 2 quarters · filed 2026-03-12 | -$80.48M derived: sum of 3 quarters · filed 2026-03-12 | -$79.31M derived: sum of 4 quarters · filed 2026-03-12 | ||||
| 2023-12-31 | -$8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$79.14M derived: sum of 2 quarters · filed 2026-03-12 | -$77.97M derived: sum of 3 quarters · filed 2026-03-12 | -$101.89M 10-K · filed 2026-03-12 | ||||
| 2023-09-30 | -$70.34M 10-Q · filed 2024-11-12 | -$69.17M derived: sum of 2 quarters · filed 2024-11-12 | -$93.09M 10-Q · filed 2024-11-12 | -$87.31M derived: sum of 4 quarters · filed 2025-03-12 | ||||
| 2023-06-30 | $1.17M 10-Q · filed 2024-08-08 | -$22.75M 10-Q · filed 2024-08-08 | -$16.97M derived: sum of 3 quarters · filed 2025-03-12 | -$17.87M derived: sum of 4 quarters · filed 2025-03-12 | ||||
| 2023-03-31 | -$23.92M 10-Q · filed 2024-05-09 | -$25.95M 10-Q · filed 2023-05-10 | -$18.14M derived: sum of 2 quarters · filed 2025-03-12 | -$19.05M derived: sum of 3 quarters · filed 2025-03-12 | -$12.65M derived: sum of 4 quarters · filed 2025-03-12 | |||
| 2022-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $4.88M derived: sum of 2 quarters · filed 2025-03-12 | $11.27M derived: sum of 3 quarters · filed 2025-03-12 | $45.34M 10-K · filed 2025-03-12 | $45.03M 10-K · filed 2023-03-01 | |||
| 2022-09-30 | -$902.00K 10-Q · filed 2023-11-14 | -$690.00K 10-Q · filed 2022-11-09 | $5.49M derived: sum of 2 quarters · filed 2023-11-14 | $39.56M 10-Q · filed 2023-11-14 | $42.44M 10-Q · filed 2022-11-09 | $20.02M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-06-30 | $6.39M 10-Q · filed 2023-08-09 | $8.01M 10-Q · filed 2022-08-09 | $40.46M 10-Q · filed 2023-08-09 | $43.13M 10-Q · filed 2022-08-09 | $20.93M derived: sum of 3 quarters · filed 2024-03-12 | -$195.35M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-03-31 | $34.07M 10-Q · filed 2023-05-10 | $35.12M 10-Q · filed 2022-05-10 | $14.53M derived: sum of 2 quarters · filed 2024-03-12 | -$201.74M derived: sum of 3 quarters · filed 2024-03-12 | -$342.99M derived: sum of 4 quarters · filed 2024-03-12 | |||
| 2021-12-31 | -$19.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$235.81M derived: sum of 2 quarters · filed 2024-03-12 | -$377.06M derived: sum of 3 quarters · filed 2024-03-12 | -$380.64M 10-K · filed 2024-03-12 | -$377.35M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$216.27M 10-Q · filed 2022-11-09 | -$357.52M derived: sum of 2 quarters · filed 2022-11-09 | -$361.10M 10-Q · filed 2022-11-09 | -$371.64M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | -$141.25M 10-Q · filed 2022-08-09 | -$144.83M 10-Q · filed 2022-08-09 | -$155.37M derived: sum of 3 quarters · filed 2023-03-01 | -$158.18M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$3.58M 10-Q · filed 2022-05-10 | $13.64M 10-Q · filed 2021-07-01 | -$14.12M derived: sum of 2 quarters · filed 2023-03-01 | -$16.93M derived: sum of 3 quarters · filed 2023-03-01 | -$30.38M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | -$10.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$13.35M derived: sum of 2 quarters · filed 2023-03-01 | -$26.80M derived: sum of 3 quarters · filed 2023-03-01 | -$38.48M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | -$2.81M 10-Q · filed 2021-11-12 | -$16.26M derived: sum of 2 quarters · filed 2021-11-12 | -$27.94M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$13.45M 10-Q · filed 2021-08-13 | -$25.13M 10-Q · filed 2021-08-13 | ||||||
| 2019-12-31 | -$2.94M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |